High expression levels of TIM-3 are negatively associated with patient survival in multiple solid tumors, such as bladder cancer, lung cancer, gastric cancer, ovarian cancer, cervical cancer, hepatocellular carcinoma, and clear cell renal cell carcinoma (17). This evidence concerns the gene HAVCR2 and ovarian cancer.